Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Quest Pharmatech Inc

QPT.V ✓ COMPLIANT ☆ Track — members

TSX Venture · Healthcare · Biotechnology & Medical Research ·

Canada Micro Cap Analyst: N/A

Last Close

$0.01

▲ +0.00%

Market Cap $2.45M · Vol 75

Key Metrics

P/E Ratio

0.68

FWD: N/A

Market Cap

$2.45M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

-0.31

vs Market

52W High

$0.04

N/A below

52W Low

$0.01

N/A above

Volume

Avg 9.29K

P/B

0.22

Price-to-book

ROE

N/A

Return on equity

Free Float

83.12%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Quest Pharmatech Inc (QPT.V) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does QPT.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-20.00%

-42.86%

-33.33%

YTD

-42.86%

-50.00%

-71.96%

-76.47%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$3.67M
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	19.87% · 20.15%

P/E Ratio	0.68
Forward P/E (FY1)	N/A
PEG Ratio	0.00
P/S	N/A
P/B	0.22
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	169.13M

Technical Indicators

50-Day SMA	$0.02
200-Day SMA	$0.02
RSI (14)	50.00
Beta	-0.31
52-Week High	$0.04
52-Week Low	$0.01

Volume Today	75
Avg Daily Volume (30D)	9.29K
Relative Volume	0.01x
Volatility (10D)	157.79
Volatility (30D)	192.89
Free Float	83.12%

Analyst Consensus

N/A

Current Price $0.01

Mean Target N/A

52W Low$0.01 52W High$0.04

Current

Target

$0.01 $0.04

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG001SB8SG5

ISINCA74836M1068

CountryCanada

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG +1.09% ONC BeOne Medicines AG +1.44% RVMD Revolution Medicines Inc -1.07% 068270.KS Celltrion Inc -0.93% ABVX Abivax SA -2.75%

Company Profile

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.